Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: Scenesse, Reyvow, and Beovu Make Trio Of Novel Approvals

Keeping Track Feature image

Related Content

Keeping Track: A Week Of Calm As Shutdown Drags On

Jan 12 2019

Boehringer Avoids Further Efficacy Study Of Ofev In SSc-ILD With Full Approval, No Post-Marketing Commitments

Sep 10 2019

US FDA Needs More Time To Review Clinuvel’s Scenesse For Phototoxicity

Jun 03 2019

Keeping Track: US FDA, Industry Roar Into Fourth Quarter With Bevy Of Regulatory Announcements

Oct 06 2019

Pfenex Gets US Teriparatide Nod

Oct 07 2019

Keeping Track: A Lilly Breast Cancer Approval, A Couple Of CRLs, And A Plethora Of Priority Reviews

Oct 02 2017

Clinuvel’s US Filing For EPP Drug Scenesse Includes Real World Evidence From Europe

Jun 27 2018

Keeping Track: Approvals For Xultophy, Soliqua And Darzalex; NDAs From Intarcia And GSK; Complete Response For Green Cross

Nov 26 2016

Lilly's Lasmiditan NDA Review Could Hinge On US FDA's Migraine Guidance

Nov 26 2018

Novartis Secures FDA Priority Review For Brolucizumab Thanks To PRV

Apr 16 2019

Pfenex And Alvogen May Face Delay In Teriparatide Equivalence Rating

Aug 15 2019

Keeping Track: FDA Clears Motegrity And Second Herceptin Biosimilar, But Rebuffs SpecGx's Oxycodone

Dec 17 2018

Regeneron's Less Frequent Eylea Dosing Makes Late Sprint Across FDA Finish Line

Aug 17 2018

Label Battles: Beovu And Eylea Contest Begins In AMD

Oct 08 2019

Related Companies

Clinuvel Pharmaceuticals Limited

Eli Lilly and Company

Novartis AG

Pelican Technology Holdings, Inc.

Octapharma AG

Boehringer Ingelheim GmbH

Intarcia Therapeutics, Inc.

Regeneron Pharmaceuticals, Inc.

Alvogen, Inc.

Roche Holding AG

Additional Topics

United States Approvals Drug Review Regulation US FDA Performance Tracker BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window